• Join Us at the 40th Annual GAPHC Conference!

    The 40th Annual Georgia Association for Primary Health Care (GAPHC) Conference is drawing near! October 10-12, we will be gathering in Atlanta, Georgia for the conference to celebrate its 40th year and to discuss topics vital to 340B Program compliance, such as FQHCs, leadership development, TeleHealth, IT/Data Informatics, finances and more. View the tentative schedule… Read more »

  • Working Together for Program Compliance

    Attending the Second Annual Council of Pharmacy Executives and Suppliers (CPES) October 4-5 in Franklin, Tennessee? Our team at RxStrategies can’t wait to connect with leading pharmacy executives in the industry as we work together to ensure 340B Program compliance.   Network with any of our team members attending the conference: Skip Devanny – Chief… Read more »

  • Ensuring Mission Achievement at the APHCA Annual Conference and Trade Show!

    RxStrategies is proud to be a Platinum Level Sponsor of this year’s Alabama Primary Health Care Association (APHCA) 32nd Annual Conference and Trade Show, being held October 3-6 at the Perdido Beach Resort in Orange Beach, Alabama. This year’s focus is “Mission Achievement: All Systems Go,” and will inform and empower key decision makers and… Read more »

  • Clinical Insights: September 22, 2017

    Welcome to the weekly edition of RxStrategies Clinical Insights, designed to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy market place.   New Drug Approval Solosec™ (secnidazole) – September 18, 2017 – Symbiomix Therapeutics announced the U.S. Food and Drug Administration (FDA) has approved Solosec™ (secnidazole) 2g oral granules for the… Read more »

  • Connect with us at the Pharmacy Systems Inc. Annual Conference!

    RxStrategies is proud to be a Level 3 Sponsor for the PSI Annual Meeting. Our team members Todd Hudnall, National Sales Manager, Midwest Region and Jonathan Ghenn, Vice President of Split Billing/Enterprise Sales, will be attending the Pharmacy Systems Inc. Annual Conference October 2-3 in Dublin, Ohio. They look forward to connecting with pharmacy leaders… Read more »

  • Clinical Insights: September 15, 2017

    Welcome to the weekly edition of RxStrategies Clinical Insights, designed to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy market place.   New Drug Approval Aliqopa™ (copanlisib) – September 14, 2017 – The U.S. Food and Drug Administration granted accelerated approval to Aliqopa™ (copanlisib) for the treatment of adults with relapsed… Read more »

  • Temporary Corporate Office Closure Due To Hurricane Irma

    RxStrategies’ corporate office is based in South Florida, and as such, the area is recovering from the impact of Hurricane Irma.  As local authorities work to clear roadways and restore power to the area, RxStrategies’ corporate office will remain closed on Wednesday, September 13. We will continue to keep you updated regarding when the corporate office will be operational.… Read more »

  • Clinical Insights: August 25, 2017

    Welcome to the weekly edition of RxStrategies Clinical Insights, designed to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy market place.   New Drug Approval Gocovri™ (amantadine) – August 24, 2017 – Adamas Pharmaceuticals, Inc., announced that the U.S. Food and Drug Administration (FDA) has approved Gocovri™ (amantadine) extended release capsules… Read more »

  • Clinical Insights: August 18, 2017

    Welcome to the weekly edition of RxStrategies Clinical Insights, designed to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy market place.   New Drug Approval Besponsa® (inotuzumab ozogamicin) – August 17, 2017 – The U.S. Food and Drug Administration approved Besponsa® (inotuzumab ozogamicin) for the treatment of adults with relapsed or… Read more »

  • Clinical Insights: August 11, 2017

    Welcome to the weekly edition of RxStrategies Clinical Insights, designed to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy market place.   New Drug Approval CaroSpir® (spironolactone) – August 7, 2017 – CMP Pharma announced that the U.S. Food and Drug Administration (FDA) has granted final approval of the company’s New… Read more »